Regulatory T-cells CD4+CD25+Foxр3+ in patients with remitting multiple sclerosis

Cover Page


Cite item

Full Text

Abstract

In the maintenance of immunological tolerance a recently discovered population of regulatory T-cells CD4+CD25+Foxp3+ (Treg) plays an important role. These cells have potential in suppressing pathologic immune response observed in various autoimmune diseases, including multiple sclerosis. In the present work, we showed reduction in the number and functional activity of Treg in peripheral blood of patients with multiple sclerosis in the acute stage, as well as increase in Treg content in the disease remission and relation of the Treg content with duration of the autoimmune process and the degree of disability of patients.

 
 

About the authors

D. D. Eliseeva

Research Center of Neurology, Russian Academy of Medical Sciences

Email: delis.82@mail.ru
Россия, Moscow

I. A. Zavalishin

Research Center of Neurology, Russian Academy of Medical Sciences

Email: delis.82@mail.ru
Россия, Moscow

S. N. Bykovskaya

Russian State Medical University named after N.I. Pirogov

Email: delis.82@mail.ru
Россия, Moscow

T. N. Fedorova

Research Center of Neurology, Russian Academy of Medical Sciences

Email: delis.82@mail.ru
Россия, Moscow

E. N. Karandashov

Russian State Medical University named after N.I. Pirogov

Email: delis.82@mail.ru
Россия, Moscow

O. A. Trunova

Research Center of Neurology, Russian Academy of Medical Sciences

Author for correspondence.
Email: delis.82@mail.ru
Россия, Moscow

References

  1. Быковская С.Н., Насонов Е.Л. Роль дефектов иммуносупрессии в развитии аутоиммунных заболеваний. Научно-практическая ревматология 2005; 4: 81–84.
  2. Воробьев А.А., Быковская С.Н., Пашков Е.П., Быков А.С. Роль клеток-регуляторов CD4+CD25+ в развитии хронических инфекционных заболеваний. Вестн. РАМН 2006; 9-10: 24–29.
  3. Завалишин И.А., Головкин В.И. Рассеянный склероз. Избранные вопросы теории и практики. М., 2000.
  4. Корсунский И.А., Румянцев А.Г., Быковская С.Н. Роль регуляторных Т-клеток CD4+CD25+ и мезенхимальных стволовых клеток костного мозга в подавлении реакции трансплантат против хозяина. Онкогематология 2008; 3, 45–51.
  5. Насонов Е.Л., Быковская С.Н. Т-регуляторные клетки при аутоиммунных ревматических заболеваниях. Вестн. РАМН 2006; 9–10: 74–82.
  6. Borsellino G. Expression of ectonucleotidase CD39 by Foxp3+ TREG cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225–1232.
  7. Braitch M., Harikrishnan S., Robins R.A. at al. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol. Scand. 2009; 119: 239–245.
  8. Buckner J.H., Ziegler S.F. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthrit Res. Ther. 2004; 6: 215–222.
  9. Cottrez F., Groux H. Specialisation in tolerance: innate CD4+CD25+ versus acquired TR1 and TH3 regulatory T cells. Transplantation 2004; 77: S12–S15.
  10. Dejaco C., Duftner C., Grubeck-Loebenstein B., Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 2006; 117: 289–300.
  11. Feger U. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 2007; 110: 568–577.
  12. Fletcher J.M., Lalor S.J., Sweeney C.M. et al. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010; 162: 1–11.
  13. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis – the plaque and its pathogenesis. N. Engl. J. Med. 2006; 354: 942–955.
  14. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002; 195: 695–704.
  15. Groux H. An Overview of regulatory T cells. Microbes Infect. 2001; 3: 883–889.
  16. Haas J., Hug A., Viehцver A. et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 2005; 35: 3343–3352.
  17. Hall B.M., Pearce N.W., Gurley K.E., Dorsch S.E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J. Exp. Med. 1990; 171: 141–157.
  18. Huan J. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res, 2005; 81: 45–52.
  19. Jiang S., Lechler R.I., He X.S., Huang J.F. Regulatory T cells and transplantation tolerance. Hum. Immunol. 2006; 67: 765–776.
  20. Lyssik E.Y., Torgashina A.V., Soloviev S.K. et al. Reduced number and function of CD4+CD25highFoxp3 regulatory T cells in patient with systemic lupus erythematosus. Adv. Exper. Med. Biol 2007; 601: 113–119.
  21. McDonald W.I., Compston A., Edan G. et al. Recommended diagnostic criateria for multiple sclerosis: guidelines for the International Panel on diagnosis of multiple sclerosis. Ann. Neurol. 2001; 50: 121–127.
  22. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001; 194: 629–644.
  23. Putheti P. Circulating CD4+CD25+T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 2004; 24: 155–161. ОРИГИНАЛЬНЫЕ СТАТЬИ. Клиническая неврология Регуляторные Т-клетки при рассеянном склерозе 13
  24. Sakaguchi S., Ono M., Setoguchi R. et al. Foxp3+ CD4+CD25+ natural regulatory T cells in dominant self-tolerance and autoimmune diseases. J. Immunol. 2006; 212: 8–27.
  25. Sakaguchi S., Sakaguchi N., Asano M. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alfachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151–1164.
  26. Sanchez J., Casaсo J., Alvarez M.A. et al. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Haematol. 2004; 126: 697–703.
  27. Saresella M., Marventano I., Longhi R. et al. CD4+CD25+Foxp3+PD1-regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy. FASEB J. 2008; 22: 3500–3508.
  28. Venken K., Hellings N., Liblau R., Stinissen P. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol. Med. 2010; 16: 58–68.
  29. Venken K. Compromised CD4+ CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008; 123: 79–89.
  30. Viglietta V., Baercher-Allan C., Weiner H.L., Haefer D.A. Human CD4+CD25+ regulatory T cells J. Exp Med. 2004; 199: 971–972.
  31. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445: 766–770.
  32. Zhou J., Carr R.I., Liwski R.S. et al. Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J. Immunol. 2001; 167: 107–113.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Eliseeva D.D., Zavalishin I.A., Bykovskaya S.N., Fedorova T.N., Karandashov E.N., Trunova O.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies